title: Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin-Preliminary report.
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Casalta
authors.forename: Caroline
authors.initials: C
authors.lastname: Zaratzian
authors.forename: Sandrine
authors.initials: S
authors.lastname: Hubert
authors.forename: Franck
authors.initials: F
authors.lastname: Thuny
authors.forename: Frédérique
authors.initials: F
authors.lastname: Gouriet
authors.forename: Gilbert
authors.initials: G
authors.lastname: Habib
authors.forename: Dominique
authors.initials: D
authors.lastname: Grisoli
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Deharo
authors.forename: Didier
authors.initials: D
authors.lastname: Raoult
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006801:Humans; D011446:Prospective Studies; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D002981:Clindamycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination